$EQH

Equitable Holdings, Inc. (EQH): Results of Operations and Financial Condition

Equitable Holdings, Inc. (EQH) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 eqh2q2026qfsdocument.htm EX-99.2 Document Table of Contents Consolidated Financials and Key Metrics Page Key Metrics Summary 4 Consolidated Statements of Income (Loss) 5 Consolidated Balance Sheets 6 Consolidated Capital Structure 7 Operating Earnings (Loss) by Segment

Original reporting
Published Aug 4, 2026, 8:14 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 8:19 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$EQH
Neutral
medium confidence
Mentioned
$EQH
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$EQHNeutralMed
01

Why it matters

EQH’s filing updates traders on quarter and year-to-date performance, highlighting a large GAAP net loss but higher non-GAAP operating earnings, alongside changes in revenues, policy benefits, and derivative-related items.

02

Market read

This is a fresh, primary disclosure of 2Q 2026 financial results and capital metrics that can shift near-term positioning around GAAP versus non-GAAP earnings quality and balance-sheet optics.

03

What to watch

Capital structure and equity metrics (including AOCI and preferred stock) can materially affect perceived balance-sheet strength even when operating earnings improve.

Relevance 7/10Novelty 6/10Timing: filed after market close on 2026-08-04

Background

The SEC 8-K includes Item 2.02 and an EX-99.2 financial supplement for 2Q 2026 with consolidated income statement, balance sheet, capital metrics, and key operating measures.

Company-level read

Ticker impact

$EQHNeutralMedium confidence
Context

Equitable Holdings filed an 8-K with its 2Q 2026 financial supplement showing GAAP net loss of $353M and non-GAAP operating earnings of $488M for 6/30/2026.

Expected impact

Near-term price reaction is likely modest and driven by how traders interpret GAAP volatility versus non-GAAP operating earnings and capital metrics.

Evidence & confidence

This is a primary-source earnings-style update (8-K exhibit) with multiple line-item changes (net derivative losses, policy benefits, and non-GAAP operating earnings). However, the excerpt does not include management guidance or a clear single catalyst beyond the reported results.

Market effects

Life insurers and asset managers may see read-across on how non-GAAP operating earnings are holding up despite GAAP volatility from derivatives and market risk benefits.

Primarily US-focused for EQH and peers with similar accounting sensitivities.

Limited global spillover; mostly affects US insurance/wealth-management sentiment.

Counterpoint

Traders may discount the non-GAAP operating earnings improvement if GAAP results remain dominated by derivative and market-risk benefit remeasurement swings.

Key entities

  • Equitable Holdings, Inc.

    Subject of the SEC 8-K, providing 2Q 2026 results and financial condition metrics.

  • AllianceBernstein L.P.

    Referenced in the supplement for AB-related market value and economic interest adjustments.

Related articles

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.

$HBBMed

Hamilton Beach Brands Q2 Earnings Call Highlights

Hamilton Beach Brands (HBB) reported Q2 gross margin of 26.1% excluding tariff-related benefits, and said it expects 2026 revenue growth in the mid-single-digit range. Management forecast full-year gross margin to improve modestly and operating profit to decline by a high-single-digit percentage. Operating cash flow is expected at $35M to $45M. HBB ended with net cash of $51.5M.

$GXOMed

GXO Logistics Q2 Earnings Call Highlights

GXO Logistics reported Q2 results and said it secured over $1 billion in expected incremental new-business revenue for 2026 and about $353 million for 2027. Management cited a $2.7 billion sales pipeline after quarter end. Operating cash flow was $76 million, free cash flow positive $12 million, cash $769 million, and net leverage 2.6x. GXO plans to target EBIT margins above 6% and deploy AI across ~50 sites in 2026.

$GRNDMed

Grindr Q2 Earnings Call Highlights

Grindr (NYSE:GRND) said free users remain central to its strategy, while AI tools are boosting engineering productivity. Management estimated engineering output rose about 2.5x from July 2025 to April 2026 with similar headcount, supporting a 39% to 42% adjusted EBITDA margin outlook. EDGE AI premium tier rollout is planned for later in fall; operating expenses ex cost of revenue were $71M vs $53M.

$HAEMedAI 8/10

Haemonetics Q1 Earnings Call Highlights

Haemonetics (NYSE:HAE) reported Q1 interventional technologies returning to 3% organic growth, with vascular closure led by VASCADE MVP and MVP XL momentum in the U.S. Apheresis revenue rose 6% organically to $191M and plasma revenue grew 8% organically as Persona PLUS rollout accelerates. Haemonetics raised FY2027 revenue guidance to 5% to 8% reported and 4% to 7% organic.